Joseph D Khoury, M.D.

Peer-Reviewed Articles

1. Bleeke M, Johann P, Gröbner S, Alten J, Cario G, Schäfer H, Klapper W, Khoury JD Pfister S, Müller I. Genome-wide analysis of acute leukemia and clonally related histiocytic sarcoma in a series of three pediatric patients. Pediatr Blood Cancer 67(2):e28074, 2020. e-Pub 2019. PMID: 31737984.
2. Yilmaz M, Kantarjian H, Wang X, Khoury JD, Ravandi F, Jorgensen J, Short NJ, Loghavi S, Cortes J, Garcia-Manero G, Kadia T, Sasaki K, Konopleva M, Takahashi K, Wierda W, Jain N, Verstovsek S, Estrov Z, Bose P, Pierce S, Garris R, O'Brien S, Jabbour E. The early achievement of measurable residual disease negativity in the treatment of adults with Philadelphia-negative B-cell acute lymphoblastic leukemia is a strong predictor for survival. Am J Hematol 95(2):144-150, 2020. e-Pub 2019. PMID: 31682008.
3. Sukswai N, Lyapichev K, Khoury JD, Medeiros LJ. Diffuse large B-cell lymphoma variants: an update. Pathology 52(1):53-67, 2020. e-Pub 2019. PMID: 31735345.
4. Xiu Y, Dong Q, Fu L, Bossler A, Tang X, Boyce B, Borcherding N, Leidinger M, Sardina JL, Xue HH, Li Q, Feldman A, Aifantis I, Boccalatte F, Wang L, Jin M, Khoury JD, Wang W, Hu S, Yuan Y, Wang E, Yuan J, Janz S, Colgan J, Habelhah H, Waldschmidt T, Müschen M, Bagg A, Darbro B, Zhao C. Coactivation of NF-κB and Notch signaling is sufficient to induce B cell transformation and enables B-myeloid conversion. Blood 135(2):108-120, 2020. e-Pub 2019. PMID: 31697816.
5. Gunther JR, Park C, Dabaja BS, Milgrom SA, Cruz Chamorro RJ, Medeiros LJ, Khoury JD, Garg N, Amini B, Steiner R, Nair R, Strati P, Westin JR, Lee HJ, Fowler N, Nastoupil L, Neelapu SS, Pinnix CC. Radiation therapy for salivary gland MALT lymphoma: ultra-low dose treatment achieves encouraging early outcomes and spares salivary function. Leuk Lymphoma 61(1):1-5, 2020. e-Pub 2019. PMID: 31373240.
6. Aladily TN, Mansour AT, Mahgoob R, Khoury JD, Oltulu P, Medeiros LJ. Epstein - Barr virus infection in de novo diffuse large B-cell lymphoma in Jordan and Turkey. Ann Diagn Pathol 43:151406, 2019. e-Pub 2019. PMID: 31499264.
7. Beird HC, Khan M, Wang F, Alfayez M, Cai T, Zhao L, Khoury J, Futreal PA, Konopleva M, Pemmaraju N. Features of non-activation dendritic state and immune deficiency in blastic plasmacytoid dendritic cell neoplasm (BPDCN). Blood Cancer J 9(12):99, 2019. e-Pub 2019. PMID: 31811114.
8. Compton CC, Robb JA, Anderson MW, Berry AB, Birdsong GG, Bloom KJ, Branton PA, Crothers JW, Cushman-Vokoun AM, Hicks DG, Khoury JD, Laser J, Marshall CB, Misialek MJ, Natale KE, Nowak JA, Olson D, Pfeifer JD, Schade A, Vance GH, Walk EE, Yohe SL. Preanalytics and Precision Pathology: Pathology Practices to Ensure Molecular Integrity of Cancer Patient Biospecimens for Precision Medicine. Arch Pathol Lab Med 143(11):1346-1363, 2019. e-Pub 2019. PMID: 31329478.
9. Tallis E, Loghavi S, Jorgensen JL, Wang S, Khoury JD, Bueso-Ramos CB, Jain N, Borthakur G, Pemmaraju N. Patient with mixed-phenotype acute leukemia with CBFB rearrangement. Leuk Lymphoma 60(11):2829-2831, 2019. e-Pub 2019. PMID: 31012358.
10. Lyapichev KA, Kurt H, Sukswai N, Konoplev S, Bueso-Ramos CE, Khoury JD, Huh YO. Chronic lymphocytic leukemia with plasmacytic differentiation. Ann Hematol 98(10):2437-2438, 2019. e-Pub 2019. PMID: 31451834.
11. Zuo Z, Li S, Xu J, You MJ, Khoury JD, Yin CC. Philadelphia-Negative Myeloproliferative Neoplasms: Laboratory Workup in the Era of Next-Generation Sequencing. Curr Hematol Malig Rep 14(5):376-385, 2019. PMID: 31388824.
12. Yap K, Cohen EN, Reuben JM, Khoury JD. Circulating Tumor Cells: State-of-the-art Update on Technologies and Clinical Applications. Curr Hematol Malig Rep 14(5):353-357, 2019. PMID: 31364034.
13. El Achi H, Khoury JD, Loghavi S. Liquid Biopsy by Next-Generation Sequencing: a Multimodality Test for Management of Cancer. Curr Hematol Malig Rep 14(5):358-367, 2019. PMID: 31346903.
14. Sukswai N, Khoury JD. Immunohistochemistry Innovations for Diagnosis and Tissue-Based Biomarker Detection. Curr Hematol Malig Rep 14(5):368-375, 2019. PMID: 31338668.
15. Sukswai N, Aung PP, Yin CC, Li S, Wang W, Wang SA, Ortega V, Lyapichev K, Nagarajan P, Alfattal R, Angelova E, Tang Z, Loghavi S, Kanagal-Shamanna R, Miranda RN, Pemmaraju N, Bhalla K, Konopleva M, Medeiros LJ, Khoury JD. Dual Expression of TCF4 and CD123 Is Highly Sensitive and Specific For Blastic Plasmacytoid Dendritic Cell Neoplasm. Am J Surg Pathol 43(10):1429-1437, 2019. PMID: 31261288.
16. Ayoub Z, Andraos T, Milgrom SA, Pinnix CC, Dabaja BS, Ng SP, Gunther JR, Khoury JD, Fowler NH, Neelapu SS, Samaniego F, Fayad LE, Nastoupil LJ. Limited stage grade 3 follicular lymphoma patients can experience favorable outcomes with combined modality therapy. Leuk Lymphoma 60(10):2432-2440, 2019. e-Pub 2019. PMID: 30942648.
17. Lyapichev KA, Sukswai N, Konoplev S, Khoury JD. Blastic plasmacytoid dendritic cell neoplasm with unusual lymphoid features and macrovacuoles. Ann Hematol 98(9):2221-2222, 2019. e-Pub 2019. PMID: 30955062.
18. Swaminathan M, Borthakur G, Kadia TM, Ferrajoli A, Alvarado Y, Pemmaraju N, Bodden K, Yearby B, Konopleva M, Khoury J, Bueso-Ramos C, Garcia-Manero G, DiNardo CD. A phase 2 clinical trial of eltrombopag for treatment of patients with myelodysplastic syndromes after hypomethylating-agent failure. Leuk Lymphoma 60(9):2207-2213, 2019. e-Pub 2019. PMID: 30773968.
19. Sakhdari A, Ok CY, Patel KP, Kanagal-Shamanna R, Yin CC, Zuo Z, Hu S, Routbort MJ, Luthra R, Medeiros LJ, Khoury JD, Loghavi S. TP53 mutations are common in mantle cell lymphoma, including the indolent leukemic non-nodal variant. Ann Diagn Pathol 41:38-42, 2019. e-Pub 2019. PMID: 31132650.
20. Khogeer H, Rahman H, Jain N, Angelova EA, Yang H, Quesada A, Ok CY, Sui D, Wei P, Al Fattani A, Pierce S, Loghavi S, Lamb A, Hu P, Thakral B, Kanagal-Shamanna R, Jorgensen JL, Jabbour EJ, Kantarjian HM, Medeiros LJ, Khoury JD. Early T precursor acute lymphoblastic leukaemia/lymphoma shows differential immunophenotypic characteristics including frequent CD33 expression and in vitro response to targeted CD33 therapy. Br J Haematol 186(4):538-548, 2019. e-Pub 2019. PMID: 31115909.
21. Ning MS, Pinnix CC, Chapman BV, Gunther JR, Milgrom SA, Khoury JD, Jain P, Chen WY, Oriabure ON, Badillo MR, Wang LM, Dabaja BS. Low-dose radiation (4 Gy) with/without concurrent chemotherapy is highly effective for relapsed, refractory mantle cell lymphoma. Blood Adv 3(13):2035-2039, 2019. PMID: 31289030.
22. Mill CP, Fiskus W, DiNardo CD, Qian Y, Raina K, Rajapakshe K, Perera D, Coarfa C, Kadia TM, Khoury JD, Saenz DT, Saenz DN, Illendula A, Takahashi K, Kornblau SM, Green MR, Futreal AP, Bushweller JH, Crews CM, Bhalla KN. RUNX1-targeted therapy for AML expressing somatic or germline mutation in RUNX1. Blood 134(1):59-73, 2019. e-Pub 2019. PMID: 31023702.
23. Quesada AE, Routbort MJ, DiNardo CD, Bueso-Ramos CE, Kanagal-Shamanna R, Khoury JD, Thakral B, Zuo Z, Yin CC, Loghavi S, Ok CY, Wang SA, Tang Z, Bannon SA, Benton CB, Garcia-Manero G, Kantarjian H, Luthra R, Medeiros LJ, Patel KP. DDX41 mutations in myeloid neoplasms are associated with male gender, TP53 mutations and high-risk disease. Am J Hematol 94(7):757-766, 2019. e-Pub 2019. PMID: 30963592.
24. Saenz DT, Fiskus W, Manshouri T, Mill CP, Qian Y, Raina K, Rajapakshe K, Coarfa C, Soldi R, Bose P, Borthakur G, Kadia TM, Khoury JD, Masarova L, Nowak AJ, Sun B, Saenz DN, Kornblau SM, Horrigan S, Sharma S, Qiu P, Crews CM, Verstovsek S, Bhalla KN. Targeting nuclear β-catenin as therapy for post-myeloproliferative neoplasm secondary AML. Leukemia 33(6):1373-1386, 2019. e-Pub 2018. PMID: 30575820.
25. Pinnix CC, Gunther JR, Milgrom SA, Cruz Chamorro RJ, Medeiros LJ, Khoury JD, Amini B, Neelapu S, Lee HJ, Westin J, Fowler N, Nastoupil L, Dabaja B. Outcomes After Reduced-Dose Intensity Modulated Radiation Therapy for Gastric Mucosa- Associated Lymphoid Tissue (MALT) Lymphoma. Int J Radiat Oncol Biol Phys 104(2):447-455, 2019. e-Pub 2019. PMID: 30769175.
26. Yan B, Chen Q, Shimada K, Tang M, Li H, Gurumurthy A, Khoury JD, Xu B, Huang S, Qiu Y. Histone deacetylase inhibitor targets CD123/CD47-positive cells and reverse chemoresistance phenotype in acute myeloid leukemia. Leukemia 33(4):931-944, 2019. e-Pub 2018. PMID: 30291336.
27. Angelova E, Audette C, Kovtun Y, Daver N, Wang SA, Pierce S, Konoplev SN, Khogeer H, Jorgensen JL, Konopleva M, Zweidler-McKay PA, Medeiros LJ, Kantarjian HM, Jabbour EJ, Khoury JD. CD123 expression patterns and selective targeting with a CD123-specific antibody-drug conjugate (IMGN632) in acute lymphoblastic leukemia. Haematologica 104(4):749-755, 2019. e-Pub 2018. PMID: 30361418.
28. Ludmir EB, Milgrom SA, Pinnix CC, Gunther JR, Westin J, Fayad LE, Khoury JD, Medeiros LJ, Dabaja BS, Nastoupil LJ. Emerging Treatment Strategies for Primary Breast Extranodal Marginal Zone Lymphoma of Mucosa-associated Lymphoid Tissue. Clin Lymphoma Myeloma Leuk 19(4):244-250, 2019. e-Pub 2019. PMID: 30686775.
29. Boddu P, Thakral B, Alhuraiji A, Pemmaraju N, Kadia T, Ohanian M, Ravandi F, Jabbour E, Wierda W, Khoury JD, Jain N. Distinguishing thymoma from T-lymphoblastic leukaemia/lymphoma: a case-based evaluation. J Clin Pathol 72(3):251-257, 2019. e-Pub 2018. PMID: 30467242.
30. Foshat M, Stewart J, Khoury JD, Staerkel GA, Caraway NP. Accuracy of diagnosing mantle cell lymphoma and identifying its variants on fine-needle aspiration biopsy. Cancer Cytopathol 127(1):44-51, 2019. e-Pub 2018. PMID: 30452126.
31. Kanagal-Shamanna R, Jain P, Patel KP, Routbort M, Bueso-Ramos C, Alhalouli T, Khoury JD, Luthra R, Ferrajoli A, Keating M, Jain N, Burger J, Estrov Z, Wierda W, Kantarjian HM, Medeiros LJ. Targeted multigene deep sequencing of Bruton tyrosine kinase inhibitor-resistant chronic lymphocytic leukemia with disease progression and Richter transformation. Cancer 125(4):559-574, 2019. e-Pub 2018. PMID: 30508305.
32. Garces S, Yin CC, Patel KP, Khoury JD, Manning JT, Li S, Xu J, Pina-Oviedo S, Johnson MR, González S, Molgó M, Ruiz-Cordero R, Medeiros LJ. Focal Rosai-Dorfman disease coexisting with lymphoma in the same anatomic site: a localized histiocytic proliferation associated with MAPK/ERK pathway activation. Mod Pathol 32(1):16-26, 2019. e-Pub 2018. PMID: 30323237.
33. Yoder AK, Gunther JR, Milgrom SA, Mirkovic D, Nastoupil L, Neelapu S, Fanale M, Fowler N, Westin J, Lee HJ, Rodriguez MA, Iyer SP, Fayad L, Nieto YL, Hosing C, Ahmed S, Medeiros LJ, Khoury JD, Garg N, Amini B, Dabaja BS, Pinnix CC. Hitting a Moving Target: Successful Management of Diffuse Large B-cell Lymphoma Involving the Mesentery With Volumetric Image-guided Intensity Modulated Radiation Therapy. Clin Lymphoma Myeloma Leuk 19(1):e51-e61, 2019. e-Pub 2018. PMID: 30360985.
34. Fiskus W, Cai T, DiNardo CD, Kornblau SM, Borthakur G, Kadia TM, Pemmaraju N, Bose P, Masarova L, Rajapakshe K, Perera D, Coarfa C, Mill CP, Saenz DT, Saenz DN, Sun B, Khoury JD, Shen Y, Konopleva M, Bhalla KN. Superior efficacy of cotreatment with BET protein inhibitor and BCL2 or MCL1 inhibitor against AML blast progenitor cells. Blood Cancer J 9(2):4, 2019. e-Pub 2019. PMID: 30647404.
35. Garces S, Khoury JD, Kanagal-Shamanna R, Salem A, Wang SA, Ok CY, Hu S, Patel KP, Routbort MJ, Luthra R, Tang G, Schlette EJ, Bueso-Ramos CE, Medeiros LJ, Loghavi S. Chronic lymphocytic leukemia with proliferation centers in bone marrow is associated with younger age at initial presentation, complex karyotype and TP53 disruption. Hum Pathol 82:215-231, 2018. e-Pub 2018. PMID: 30086334.
36. Loghavi S, Khoury JD. Recent Updates on Chronic Myelomonocytic Leukemia. Curr Hematol Malig Rep 13(6):446-454, 2018. e-Pub 2018. PMID: 30311069.
37. Sanz-De Pedro M, Wang W, Kanagal-Shamanna R, Khoury JD. Myelodysplastic Syndromes: Laboratory Workup in the Context of New Concepts and Classification Criteria. Curr Hematol Malig Rep 13(6):467-476, 2018. e-Pub 2018. PMID: 30338456.
38. Khoury JD. Blastic Plasmacytoid Dendritic Cell Neoplasm. Curr Hematol Malig Rep 13(6):477-483, 2018. e-Pub 2018. PMID: 30350260.
39. Jabbour E, Short NJ, Ravandi F, Huang X, Daver N, DiNardo CD, Konopleva M, Pemmaraju N, Wierda W, Garcia-Manero G, Sasaki K, Cortes J, Garris R, Khoury JD, Jorgensen J, Jain N, Alvarez J, O'Brien S, Kantarjian H. Combination of hyper-CVAD with ponatinib as first-line therapy for patients with Philadelphia chromosome-positive acute lymphoblastic leukaemia: long-term follow-up of a single-centre, phase 2 study. Lancet Haematol 5(12):e618-e627, 2018. PMID: 30501869.
40. Curry JL, Tetzlaff MT, Wang SA, Landon G, Alouch N, Patel SP, Nagarajan P, Gupta S, Aung PP, Devine CE, Khoury JD, Loghavi S, Prieto VG, DiNardo CD, Gershenwald JE. Case Report of Myeloid Sarcoma Masquerading as In-Transit Metastasis at a Previous Melanoma Site: Avoiding a Diagnostic Pitfall. Am J Dermatopathol 40(11):831-835, 2018. e-Pub 2018. PMID: 29863571.
41. Angelova EA, Medeiros LJ, Wang W, Muzzafar T, Lu X, Khoury JD, Ravandi F, Patel KP, Hu Z, Kanagal-Shamanna R. Clinicopathologic and molecular features in hairy cell leukemia-variant: single institutional experience. Mod Pathol 31(11):1717-1732, 2018. e-Pub 2018. PMID: 29955146.
42. Assi R, Gur HD, Loghavi S, Konoplev SN, Konopleva M, Daver N, Tashakori M, Kadia T, Routbort M, Salem A, Kanagal-Shamanna R, Quesada A, Jabbour EJ, Kornblau SM, Medeiros LJ, Kantarjian H, Khoury JD. P53 Protein Overexpression in De Novo Acute Myeloid Leukemia Patients with Normal Diploid Karyotype Correlates with FLT3 Internal Tandem Duplication and Worse Relapse-Free Survival. Am J Hematol 93(11):1376-1383, 2018. e-Pub 2018. PMID: 30117185.
43. Kellner JN, Delemarre EM, Yvon E, Nierkens S, Boelens JJ, McNiece I, Olson A, Nieto Y, Ciurea S, Popat U, Ahmed S, Champlin R, Ramos J, Nishimoto M, Ma H, Ke Z, Thall P, Khoury JD, Negrin R, Andersson B, Parmar S. Third party, umbilical cord blood derived regulatory T-cells for prevention of graft versus host disease in allogeneic hematopoietic stem cell transplantation: feasibility, safety and immune reconstitution. Oncotarget 9(86):35611-35622, 2018. e-Pub 2018. PMID: 30479692.
44. Tang Z, Li Y, Wang W, Yin CC, Tang G, Aung PP, Hu S, Lu X, Toruner GA, Medeiros LJ, Khoury JD. Genomic aberrations involving 12p/ETV6 are highly prevalent in blastic plasmacytoid dendritic cell neoplasms and might represent early clonal events. Leuk Res 73:86-94, 2018. e-Pub 2018. PMID: 30248580.
45. Wei Y, Zheng H, Bao N, Jiang S, Bueso-Ramos CE, Khoury JD, Class C, Lu Y, Lin K, Yang H, Ganan-Gomez I, Starczynowski DT, Do KA, Colla S, Garcia-Manero G. KDM6B overexpression activates innate immune signaling and impairs hematopoiesis in mice. Blood Adv 2(19):2491-2504, 2018. PMID: 30275007.
46. Jabbour E, Sasaki K, Ravandi F, Huang X, Short NJ, Khouri M, Kebriaei P, Burger J, Khoury JD, Jorgensen J, Jain N, Konopleva M, Garcia-Manero G, Kadia T, Cortes J, Jacob J, Montalbano K, Garris R, O'Brien S, Kantarjian HM. Chemoimmunotherapy with inotuzumab ozogamicin combined with mini-hyper-CVD, with or without blinatumomab, is highly effective in patients with Philadelphia chromosome-negative acute lymphoblastic leukemia in first salvage. Cancer 124(20):4044-4055, 2018. e-Pub 2018. PMID: 30307611.
47. Rassidakis GZ, Herold N, Myrberg IH, Tsesmetzis N, Rudd SG, Henter JI, Schaller T, Ng SB, Chng WJ, Yan B, Ng CH, Ravandi F, Andreeff M, Kantarjian HM, Medeiros LJ, Xagoraris I, Khoury JD. Low-level expression of SAMHD1 in acute myeloid leukemia (AML) blasts correlates with improved outcome upon consolidation chemotherapy with high-dose cytarabine-based regimens. Blood Cancer J 8(11):98, 2018. e-Pub 2018. PMID: 30341277.
48. Huang W, Medeiros LJ, Lin P, Wang W, Tang G, Khoury JD, Konoplev S, Yin CC, Xu J, Oki Y, Li S. MYC/BCL2/BCL6 triple hit lymphoma: a study of 40 patients with a comparison to MYC/BCL2 and MYC/BCL6 double hit lymphomas. Mod Pathol 31(9):1470-1478, 2018. e-Pub 2018. PMID: 29785017.
49. Kurt H, Medeiros LJ, Khoury JD, Schlette EJ. Epstein-Barr virus-positive follicular lymphoma. Br J Haematol 182(6):757, 2018. e-Pub 2018. PMID: 29808924.
50. Loghavi S, Sui D, Wei P, Garcia-Manero G, Pierce S, Routbort MJ, Jabbour EJ, Pemmaraju N, Kanagal-Shamanna R, Gur HD, Hu S, Zuo Z, Medeiros LJ, Kantarjian HM, Khoury JD. Validation of the 2017 revision of the WHO chronic myelomonocytic leukemia categories. Blood Adv 2(15):1807-1816, 2018. PMID: 30054307.
51. Loghavi S, Medeiros LJ, Javadi S, Lin P, Khoury JD, Nastoupil L, Hunt KK, Clemens MW, Miranda RN. Breast Implant-Associated Anaplastic Large Cell Lymphoma With Bone Marrow Involvement. Aesthet Surg J 38(7), 2018. e-Pub 2018. PMID: 29635424.
52. Gur HD, Loghavi S, Garcia-Manero G, Routbort M, Kanagal-Shamanna R, Quesada A, Khogeer H, Pierce S, Medeiros LJ, Kantarjian H, Khoury JD. Chronic Myelomonocytic Leukemia With Fibrosis Is a Distinct Disease Subset With Myeloproliferative Features and Frequent JAK2 p.V617F Mutations. Am J Surg Pathol 42(6):799-806, 2018. PMID: 29596070.
53. Kurt H, Jorgensen JL, Amin HM, Patel KP, Wang SA, Lin P, Kanagal-Shamanna R, Loghavi S, Thakral B, Khogeer HA, Jabbour EJ, Li S, Yin CC, Medeiros LJ, Khoury JD. Chronic lymphoproliferative disorder of NK-cells: A single-institution review with emphasis on relative utility of multimodality diagnostic tools. Eur J Haematol 100(5):444-454, 2018. e-Pub 2018. PMID: 29385279.
54. Kurt H, Khoury JD, Medeiros LJ, Huh YO. Blastic plasmacytoid dendritic cell neoplasm with unusual morphology, MYC rearrangement and TET2 and DNMT3A mutations. Br J Haematol 181(3):305, 2018. e-Pub 2018. PMID: 29411884.
55. Kurt H, Bueso-Ramos CE, Khoury JD, Routbort MJ, Kanagal-Shamanna R, Patel UV, Jorgensen JL, Wang SA, Ravandi F, DiNardo C, Luthra R, Medeiros LJ, Patel KP. Characterization of IDH1 p.R132H Mutant Clones Using Mutation-specific Antibody in Myeloid Neoplasms. Am J Surg Pathol 42(5):569-577, 2018. PMID: 29635257.
56. Agbay RLMC, Loghavi S, Zuo Z, Fayad L, Dabaja B, Medeiros LJ, Khoury JD. Bone Marrow Involvement in Patients With Nodular Lymphocyte Predominant Hodgkin Lymphoma. Am J Surg Pathol 42(4):492-499, 2018. e-Pub 2018. PMID: 29309302.
57. Boddu P, Benton CB, Wang W, Borthakur G, Khoury JD, Pemmaraju N. Erythroleukemia-historical perspectives and recent advances in diagnosis and management. Blood Rev 32(2):96-105, 2018. e-Pub 2017. PMID: 28965757.
58. Jabbour E, Düll J, Yilmaz M, Khoury JD, Ravandi F, Jain N, Einsele H, Garcia-Manero G, Konopleva M, Short NJ, Thompson PA, Wierda W, Daver N, Cortes J, O'brien S, Kantarjian H, Topp MS. Outcome of patients with relapsed/refractory acute lymphoblastic leukemia after blinatumomab failure: No change in the level of CD19 expression. Am J Hematol 93(3):371-374, 2018. e-Pub 2017. PMID: 29178361.
59. Sun B, Fiskus W, Qian Y, Rajapakshe K, Raina K, Coleman KG, Crew AP, Shen A, Saenz DT, Mill CP, Nowak AJ, Jain N, Zhang L, Wang M, Khoury JD, Coarfa C, Crews CM, Bhalla KN. BET protein proteolysis targeting chimera (PROTAC) exerts potent lethal activity against mantle cell lymphoma cells. Leukemia 32(2):343-352, 2018. e-Pub 2017. PMID: 28663582.
60. Khoury JD, Wang WL, Prieto VG, Medeiros LJ, Kalhor N, Hameed M, Broaddus R, Hamilton SR. Validation of Immunohistochemical Assays for Integral Biomarkers in the NCI-MATCH EAY131 Clinical Trial. Clin Cancer Res 24(3):521-531, 2018. e-Pub 2017. PMID: 28839110.
61. Ng SB, Chung TH, Kato S, Nakamura S, Takahashi E, Ko YH, Khoury JD, Yin CC, Soong R, Jeyasekharan AD, Hoppe MM, Selvarajan V, Tan SY, Lim ST, Ong CK, Nairismägi ML, Maheshwari P, Choo SN, Fan S, Lee CK, Chuang SS, Chng WJ. EBV-associated primary nodal T/NK-cell lymphoma shows distinct molecular signature and copy number changes. Haematologica 103(2):278-287, 2018. e-Pub 2017. PMID: 29097495.
62. Kantarjian H, Ravandi F, Short NJ, Huang X, Jain N, Sasaki K, Daver N, Pemmaraju N, Khoury JD, Jorgensen J, Alvarado Y, Konopleva M, Garcia-Manero G, Kadia T, Yilmaz M, Bortakhur G, Burger J, Kornblau S, Wierda W, DiNardo C, Ferrajoli A, Jacob J, Garris R, O'Brien S, Jabbour E. Inotuzumab ozogamicin in combination with low-intensity chemotherapy for older patients with Philadelphia chromosome-negative acute lymphoblastic leukemia: a single-arm, phase 2 study. Lancet Oncol 19(2):240-248, 2018. e-Pub 2018. PMID: 29352703.
63. Akhtari M, Milgrom SA, Pinnix CC, Reddy JP, Dong W, Smith GL, Mawlawi O, Abou Yehia Z, Gunther J, Osborne EM, Andraos TY, Wogan CF, Rohren E, Garg N, Chuang H, Khoury JD, Oki Y, Fanale M, Dabaja BS. Reclassifying patients with early-stage Hodgkin lymphoma based on functional radiographic markers at presentation. Blood 131(1):84-94, 2018. e-Pub 2017. PMID: 29038339.
64. Ludmir EB, Gutschenritter T, Pinnix CC, Gunther JR, Nastoupil LJ, Khoury JD, Medeiros LJ, Dabaja BS, Milgrom SA. Coincident primary breast lymphoma and gastrointestinal stromal tumor: case series and molecular mechanisms. Onco Targets Ther 11:8937-8942, 2018. e-Pub 2018. PMID: 30573980.
65. Loghavi S, Curry JL, Garcia-Manero G, Patel KP, Xu J, Khoury JD, Torres-Cabala CA, Nagarajan P, Aung PP, Gibson BR, Goodwin BP, Kelly BC, Korivi BR, Medeiros LJ, Prieto VG, Kantarjian HM, Bueso-Ramos CE, Tetzlaff MT. Chronic myelomonocytic leukemia masquerading as cutaneous indeterminate dendritic cell tumor: expanding the spectrum of skin lesions in chronic myelomonocytic leukemia. J Cutan Pathol 44(12):1075-1079, 2017. e-Pub 2017. PMID: 28885734.
66. Ruvolo PP, Ma H, Ruvolo VR, Zhang X, Mu H, Schober W, Hernandez I, Gallardo M, Khoury JD, Cortes J, Andreeff M, Post SM. Anexelekto/MER tyrosine kinase inhibitor ONO-7475 arrests growth and kills FMS-like tyrosine kinase 3-internal tandem duplication mutant acute myeloid leukemia cells by diverse mechanisms. Haematologica 102(12):2048-2057, 2017. e-Pub 2017. PMID: 28912176.
67. Boudjemaa S, Dainese L, Khoury JD, Auvrignon A, Leverger G, Audry G, Coulomb A, Lemale J. Sporadic Burkitt Lymphoma Presenting as Intestinal Polyposis in a Child. Appl Immunohistochem Mol Morphol 25(9):e80-e81, 2017. e-Pub 2016. PMID: 27941561.
68. Jain P, Kantarjian H, Jain N, Short NJ, Yin CC, Kanagal-Shamanna R, Khoury J, Konopleva M, Sasaki K, Kadia TM, Garris R, Pierce S, Estrov Z, Wierda W, Cortes J, O'Brien S, Ravandi F, Jabbour E. Clinical characteristics and outcomes of previously untreated patients with adult onset T-ALL and T-lymphoblastic lymphoma (T-LL) with Hyper-CVAD based regimens. Am J Hematol 92(10):E595-E597, 2017. e-Pub 2017. PMID: 28646517.
69. Kanagal-Shamanna R, Loghavi S, DiNardo CD, Medeiros LJ, Garcia-Manero G, Jabbour E, Routbort MJ, Luthra R, Bueso-Ramos CE, Khoury JD. Bone marrow pathologic abnormalities in familial platelet disorder with propensity for myeloid malignancy and germline RUNX1 mutation. Haematologica 102(10):1661-1670, 2017. e-Pub 2017. PMID: 28659335.
70. Garces S, Medeiros LJ, Patel KP, Li S, Pina-Oviedo S, Li J, Garces JC, Khoury JD, Yin CC. Mutually exclusive recurrent KRAS and MAP2K1 mutations in Rosai-Dorfman disease. Mod Pathol 30(10):1367-1377, 2017. e-Pub 2017. PMID: 28664935.
71. Jain P, Burger JA, Khoury JD. CLL progression after one cycle of FCR: Richter's transformation versus EBV-associated lympho-proliferation. Am J Hematol 92(10):1113-1114, 2017. e-Pub 2017. PMID: 28670739.
72. Agbay RLMC, Medeiros LJ, Khoury JD, Salem A, Bueso-Ramos CE, Loghavi S. Characteristics and Clinical Implications of Reactive Germinal Centers in the Bone Marrow. Hum Pathol 68:7-21, 2017. e-Pub 2017. PMID: 28428103.
73. Kanagal-Shamanna R, Jain P, Takahashi K, Short NJ, Tang G, Issa GC, Ravandi F, Garcia-Manero G, Yin CC, Luthra R, Patel KP, Khoury JD, Montalban-Bravo G, Sasaki K, Kadia TM, Borthakur G, Konopleva M, Jain N, Garris R, Pierce S, Wierda W, Estrov Z, Cortes J, O'Brien S, Kantarjian HM, Jabbour E. TP53 mutation does not confer a poor outcome in adult patients with acute lymphoblastic leukemia who are treated with frontline hyper-CVAD-based regimens. Cancer 123(19):3717-3724, 2017. e-Pub 2017. PMID: 28608976.
74. Gong Z, Medeiros LJ, Cortes JE, Zheng L, Khoury JD, Wang W, Tang G, Loghavi S, Luthra R, Yang W, Kantarjian HM, Hu S. Clinical and prognostic significance of e1a2 BCR-ABL1 transcript subtype in chronic myeloid leukemia. Blood Cancer J 7(7):e583, 2017. e-Pub 2017. PMID: 28708130.
75. Salem A, Loghavi S, Tang G, Huh YO, Jabbour EJ, Kantarjian H, Wang W, Hu S, Luthra R, Medeiros LJ, Khoury JD. Myeloid Neoplasms with Concurrent BCR-ABL1 and CBFB Rearrangements: A Series of 10 Cases of a Clinically Aggressive Neoplasm. Am J Hematol 92(6):520-528, 2017. e-Pub 2017. PMID: 28253536.
76. Short NJ, Kantarjian HM, Ko H, Khoury JD, Ravandi F, Thomas DA, Garcia-Manero G, Khouri M, Cortes JE, Wierda WG, Verstovsek S, Estrov Z, Ferrajoli A, Thompson PA, Pierce S, O'Brien SM, Jabbour E. Outcomes of adults with relapsed or refractory Burkitt and high-grade B-cell leukemia/lymphoma. Am J Hematol 92(6):E114-E117, 2017. e-Pub 2017. PMID: 28295472.
77. Pina-Oviedo S, Medeiros LJ, Li S, Khoury JD, Patel KP, Alayed K, Cason RC, Bowman CJ, Yin CC. Langerhans cell histiocytosis associated with lymphoma: an incidental finding that is not associated with BRAF or MAP2K1 mutations. Mod Pathol 30(5):734-744, 2017. e-Pub 2017. PMID: 28084334.
78. Salem A, Loghavi S, Khoury JD, Agbay RL, Jorgensen JL, Medeiros LJ. Herpes simplex infection simulating Richter transformation: a series of four cases and review of the literature. Histopathology 70(5):821-831, 2017. e-Pub 2017. PMID: 27905140.
79. Thakral B, Medeiros LJ, Desai P, Lin P, Yin CC, Tang G, Khoury JD, Hu S, Xu J, Loghavi S, Hu B, Oki Y, Li S. Prognostic impact of CD5 expression in diffuse large B-cell lymphoma in patients treated with rituximab-EPOCH. Eur J Haematol 98(4):415-421, 2017. e-Pub 2017. PMID: 28039906.
80. Wang W, Wang SA, Medeiros LJ, Khoury JD. Pure erythroid leukemia. Am J Hematol 92(3):292-296, 2017. e-Pub 2017. PMID: 28006859.
81. McCroskey Z, Khoury JD, Stewart JM, Caraway NP. Sensitivity of fine-needle aspiration biopsy for diagnosing and grading follicular lymphomas using a multiparameter approach in a cancer center. J Am Soc Cytopathol 6(2):80-88, 2017.
82. Durant T, Schulz W, Khoury JD. Moving Averages: Real-Time Data Monitoring in the Clinical Chemistry Laboratory. Am J Clin Pathol 147(suppl_2):S166-S167, 2017. PMID: 28340007.
83. Loghavi S, Khoury JD. Langerhans cell histiocytosis in a patient with hairy cell leukemia: a tale of divergence. Blood 129(11):1563, 2017. PMID: 28302693.
84. Wang XJ, Jeffrey Medeiros L, Bueso-Ramos CE, Tang G, Wang S, Oki Y, Desai P, Khoury JD, Miranda RN, Tang Z, Reddy N, Li S. P53 expression correlates with poorer survival and augments the negative prognostic effect of MYC rearrangement, expression or concurrent MYC/BCL2 expression in diffuse large B-cell lymphoma. Mod Pathol 30(2):194-203, 2017. e-Pub 2016. PMID: 27739436.
85. Milgrom SA, Dong W, Akhtari M, Smith GL, Pinnix CC, Mawlawi O, Rohren E, Garg N, Chuang H, Yehia ZA, Reddy JP, Gunther JR, Khoury JD, Suki T, Osborne EM, Oki Y, Fanale M, Dabaja BS. Chemotherapy Response Assessment by FDG-PET-CT in Early-stage Classical Hodgkin Lymphoma: Moving Beyond the Five-Point Deauville Score. Int J Radiat Oncol Biol Phys 97(2):333-338, 2017. e-Pub 2016. PMID: 28068241.
86. Jabbour E, Faderl S, Sasaki K, Kadia T, Daver N, Pemmaraju N, Patel K, Khoury JD, Bueso-Ramos C, Bohannan Z, Ravandi F, Borthakur G, Verstovsek S, Miller D, Maduike R, Hosing C, Kantarjian HM, Garcia-Manero G. Phase 2 study of low-dose clofarabine plus cytarabine for patients with higher-risk myelodysplastic syndrome who have relapsed or are refractory to hypomethylating agents. Cancer 123(4):629-637, 2017. e-Pub 2016. PMID: 27741352.
87. Jabbour E, Short NJ, Jorgensen JL, Yilmaz M, Ravandi F, Wang SA, Thomas DA, Khoury JD, Champlin RE, Khouri I, Kebriaei P, O'Brien SM, Garcia-Manero G, Cortes JE, Sasaki K, Dinardo CD, Kadia TM, Jain N, Konopleva M, Garris R, Kantarjian HM. Differential impact of minimal residual disease negativity according to the salvage status in patients with relapsed/refractory B-cell acute lymphoblastic leukemia. Cancer 123(2):294-302, 2017. e-Pub 2016. PMID: 27602508.
88. Dy-Ledesma JL, Khoury JD, Agbay RL, Garcia M, Miranda RN, Medeiros LJ. Starry Sky Pattern in Hematopoietic Neoplasms: A Review of Pathophysiology and Differential Diagnosis. Adv Anat Pathol 23(6):343-355, 2016. PMID: 27677083.
89. Thakral B, Khoury JD. Histiocytic sarcoma: secondary neoplasm or "transdifferentiation" in the setting of B-acute lymphoblastic leukemia. Blood 128(20):2475, 2016. PMID: 27856472.
90. Agbay RL, Jain N, Loghavi S, Medeiros LJ, Khoury JD. Histologic transformation of chronic lymphocytic leukemia/small lymphocytic lymphoma. Am J Hematol 91(10):1036-43, 2016. e-Pub 2016. PMID: 27414262.
91. Sever C, Abbott CL, de Baca ME, Khoury JD, Perkins SL, Reichard KK, Taylor A, Terebelo HR, Colasacco C, Rumble RB, Thomas NE. Bone Marrow Synoptic Reporting for Hematologic Neoplasms: Guideline From the College of American Pathologists Pathology and Laboratory Quality Center. Arch Pathol Lab Med 140(9):932-49, 2016. e-Pub 2016. PMID: 26905483.
92. Nazha A, Khoury JD, Verstovsek S, Daver N. Second line therapies in polycythemia vera: What is the optimal strategy after hydroxyurea failure?. Crit Rev Oncol Hematol 105:112-7, 2016. e-Pub 2016. PMID: 27401783.
93. Tang Z, Li Y, Wang SA, Hu S, Li S, Lu X, Khoury JD, Medeiros LJ, Tang G. Clinical significance of acquired loss of the X chromosome in bone marrow. Leuk Res 47:109-113, 2016. e-Pub 2016. PMID: 27299973.
94. Yin CC, Peng J, Li Y, Shamanna RK, Muzzafar T, DiNardo C, Khoury JD, Li S, Medeiros LJ, Wang SA, Tang G. Clinical significance of newly emerged isolated del(20q) in patients following cytotoxic therapies. Mod Pathol 29(8):939, 2016. PMID: 27469452.
95. Kelley TW, Arber DA, Gibson C, Jones D, Khoury JD, Medeiros BC, O'Malley DP, Patel KP, Pilichowska M, Vasef MA, Wallentine J, Zehnder JL. Template for Reporting Results of Monitoring Tests for Patients With Chronic Myelogenous Leukemia (BCR-ABL1+). Arch Pathol Lab Med 140(7):672-674, 2016. e-Pub 2015. PMID: 26653363.
96. Kelley TW, Arber DA, Gibson C, Jones D, Khoury JD, Medeiros BC, O'Malley DP, Patel KP, Pilichowska M, Vasef MA, Wallentine J, Zehnder JL. Template for Reporting Results of Biomarker Testing of Specimens From Patients With Myeloproliferative Neoplasms. Arch Pathol Lab Med 140(7):675-677, 2016. e-Pub 2015. PMID: 26653364.
97. Huh YO, Tang G, Talwalkar SS, Khoury JD, Ohanian M, Bueso-Ramos CE, Abruzzo LV. Double minute chromosomes in acute myeloid leukemia, myelodysplastic syndromes, and chronic myelomonocytic leukemia are associated with micronuclei, MYC or MLL amplification, and complex karyotype. Cancer Genet 209(7-8):313-20, 2016. e-Pub 2016. PMID: 27318442.
98. Li S, Desai P, Lin P, Yin CC, Tang G, Wang XJ, Konoplev SN, Khoury JD, Bueso-Ramos CE, Medeiros LJ. MYC/BCL6 Double Hit Lymphoma (DHL): A Tumor Associated with an Aggressive Clinical Course and Poor Prognosis. Histopathology 68(7):1090-8, 2016. e-Pub 2015. PMID: 26426741.
99. Wang W, Cortes JE, Tang G, Khoury JD, Wang S, Bueso-Ramos CE, DiGiuseppe JA, Chen Z, Kantarjian HM, Medeiros LJ, Hu S. Risk stratification of chromosomal abnormalities in chronic myelogenous leukemia in the era of tyrosine kinase inhibitor therapy. Blood 127(22):2742-50, 2016. e-Pub 2016. PMID: 27006386.
100. Jain N, Lamb AV, O'Brien S, Ravandi F, Konopleva M, Jabbour E, Zuo Z, Jorgensen J, Lin P, Pierce S, Thomas D, Rytting M, Borthakur G, Kadia T, Cortes J, Kantarjian HM, Khoury JD. Early T-cell precursor acute lymphoblastic leukemia/lymphoma (ETP-ALL/LBL) in adolescents and adults: a high-risk subtype. Blood 127(15):1863-9, 2016. e-Pub 2016. PMID: 26747249.
101. Yabe M, Medeiros LJ, Tang G, Wang SA, P Patel K, Routbort M, Bhagat G, Bueso-Ramos CE, Jorgensen JL, Luthra R, Chen W, Muzzafar T, Kanagal-Shamanna R, Khoury JD, Daneshbod Y, Davanlou M, Li S, Young KH, Miranda RN. Dyspoietic changes associated with hepatosplenic T-cell lymphoma are not a manifestation of a myelodysplastic syndrome: analysis of 25 patients. Hum Pathol 50:109-17, 2016. e-Pub 2015. PMID: 26997444.
102. Kanagal-Shamanna R, Xu-Monette ZY, Miranda RN, Dogan A, Zou D, Luthra R, Weber DM, O'Malley DP, Jorgensen JL, Khoury JD, Bueso-Ramos CE, Orlowski RZ, Medeiros LJ, Young KH. Crystal-Storing Histiocytosis: A Clinicopathologic Study of 13 Cases. Histopathology 68(4):482-91, 2016. e-Pub 2015. PMID: 26118455.
103. Sevcikova K, Zhuang Z, Garcia-Manero G, Alvarez RH, Kantarjian HM, Mego M, Albarracin C, Tang G, Strom SS, Medeiros LJ, Hortobagyi GN, Reuben JM, Khoury JD. Comprehensive analysis of factors impacting risks and outcomes of therapy-related myeloid neoplasms following breast cancer treatment. Leukemia 30(1):242-7, 2016. e-Pub 2015. PMID: 25975189.
104. Agbay RL, Loghavi S, Medeiros LJ, Khoury JD. High-grade Transformation of Low-grade B-cell Lymphoma: Pathology and Molecular Pathogenesis. Am J Surg Pathol 40(1):e1-e16, 2016. PMID: 26658667.
105. Tang Z, Tang G, Wang SA, Lu X, Young KH, Bueso-Ramos CE, Alvarado Y, Medeiros LJ, Khoury JD. Simultaneous deletion of 3'ETV6 and 5'EWSR1 genes in blastic plasmacytoid dendritic cell neoplasm: case report and literature review. Mol Cytogenet 9:23, 2016. e-Pub 2016. PMID: 26925167.
106. Sarwari NM, Khoury JD, Hernandez CM. Chronic Epstein Barr virus infection leading to classical Hodgkin lymphoma. BMC Hematol 16:19, 2016. e-Pub 2016. PMID: 27437106.
107. Khoury JD. The evolving potential of companion diagnostics. Scand J Clin Lab Invest Suppl 245:1-4, 2016. e-Pub 2016. PMID: 27433788.
108. Tang Z, Medeiros LJ, Yin CC, Wang W, Lu X, Young KH, Khoury JD, Tang G. Sex chromosome loss after allogeneic hematopoietic stem cell transplant in patients with hematologic neoplasms: a diagnostic dilemma for clinical cytogeneticists. Mol Cytogenet 9:62, 2016. e-Pub 2016. PMID: 27508005.
109. Wang W, Cortes JE, Lin P, Khoury JD, Ai D, Tang Z, Tang G, Jorgensen JL, Medeiros LJ, Hu S. Impact of trisomy 8 on treatment response and survival of patients with chronic myelogenous leukemia in the era of tyrosine kinase inhibitors. Leukemia 29(11):2263-6, 2015. e-Pub 2015. PMID: 25931274.
110. Ohanian M, Bueso-Ramos C, Ok CY, Lin P, Patel K, Alattar ML, Khoury JD, Rozovski U, Estrov Z, Huh YO, Cortes J, Abruzzo LV. Acute myeloid leukemia with MYC rearrangement and JAK2 V617F mutation. Cancer Genet 208(11):571-4, 2015. e-Pub 2015. PMID: 26382622.
111. Jabbour E, Kantarjian H, Ravandi F, Thomas D, Huang X, Faderl S, Pemmaraju N, Daver N, Garcia-Manero G, Sasaki K, Cortes J, Garris R, Yin CC, Khoury JD, Jorgensen J, Estrov Z, Bohannan Z, Konopleva M, Kadia T, Jain N, DiNardo C, Wierda W, Jeanis V, O'Brien S. Combination of hyper-CVAD with ponatinib as first-line therapy for patients with Philadelphia chromosome-positive acute lymphoblastic leukaemia: a single-centre, phase 2 study. Lancet Oncol 16(15):1547-55, 2015. e-Pub 2015. PMID: 26432046.
112. Nazha A, Khoury JD, Rampal RK, Daver N. Fibrogenesis in Primary Myelofibrosis: Diagnostic, Clinical and Therapeutic Implications. Oncologist 20(10):1154-60, 2015. e-Pub 2015. PMID: 26304912.
113. Loghavi S, Al-Ibraheemi A, Zuo Z, Garcia-Manero G, Yabe M, Wang SA, Kantarjian HM, Yin CC, Miranda RN, Luthra R, Medeiros LJ, Bueso-Ramos CE, Khoury JD. TP53 overexpression is an independent adverse prognostic factor in de novo myelodysplastic syndromes with fibrosis. Br J Haematol 171(1):91-9, 2015. e-Pub 2015. PMID: 26123119.
114. Tang G, Fu B, Hu S, Lu X, Tang Z, Li S, Jabbar K, Khoury JD, Medeiros LJ, Wang SA. Prognostic Impact of Acquisition of Cytogenetic Abnormalities during the Course of Chronic Myelomonocytic Leukemia. Am J Hematol 90(10):882-7, 2015. e-Pub 2015. PMID: 26148174.
115. Yabe M, Medeiros LJ, Wang SA, Konoplev S, Ok CY, Loghavi S, Lu G, Flores L, Khoury JD, Cason RC, Young KH, Miranda RN. Clinicopathologic, Immunophenotypic, Cytogenetic, and Molecular Features of γδ T-Cell Large Granular Lymphocytic Leukemia: An Analysis of 14 Patients Suggests Biologic Differences With γδ T-Cell Large Granular Lymphocytic Leukemia. Am J Clin Pathol 144(4):607-19, 2015. PMID: 26386082.
116. Yin CC, Peng J, Li Y, Shamanna RK, Muzzafar T, DiNardo C, Khoury JD, Li S, Medeiros LJ, Wang SA, Tang G. Clinical significance of newly emerged isolated del(20q) in patients following cytotoxic therapies. Mod Pathol 28(8):1014-22, 2015. e-Pub 2015. PMID: 26044451.
117. Loghavi S, Khoury JD, Medeiros LJ. Epstein-Barr virus-positive plasmacytoma in immunocompetent patients. Histopathology 67(2):225-34, 2015. e-Pub 2015. PMID: 25556356.
118. Loghavi S, Khoury JD. Disseminated blastic plasmacytoid dendritic cell neoplasm. Blood 126(4):558, 2015. PMID: 26421330.
119. Yabe M, Tang G, Garcia-Manero G, Loghavi S, Lu X, Miranda RN, Medeiros LJ, Kantarjian HM, Bueso-Ramos CE, Khoury JD. Acute myeloid leukemia with t(v;5q33) is associated with poor overall survival and often lacks myelodysplastic features. Clin Lymphoma Myeloma Leuk 15S:S85-90, 2015. PMID: 26297286.
120. Li Y, Hu S, Zuo Z, Hong M, Lin P, Li S, Konoplev S, Wang Z, Khoury JD, Young KH, Medeiros LJ, Yin CC. CD5-positive follicular lymphoma: clinicopathologic correlations and outcome in 88 cases. Mod Pathol 28(6):787-98, 2015. e-Pub 2015. PMID: 25743023.
121. Loghavi S, Khoury JD. Unusual breast mass: lymphoma with crystal-storing histiocytosis. Blood 125(15):2445, 2015. PMID: 26038772.
122. Mego M, Zuo Z, Gao H, Cohen EN, Giordano A, Tin S, Anfossi S, Jackson S, Woodward W, Ueno NT, Valero V, Alvarez RH, Hortobagyi GN, Khoury JD, Cristofanilli M, Reuben JM. Circulating tumour cells are linked to plasma D-dimer levels in patients with metastatic breast cancer. Thromb Haemost 113(3):593-8, 2015. e-Pub 2014. PMID: 25373787.
123. Tang G, DiNardo C, Zhang L, Ravandi F, Khoury JD, Huh YO, Muzzafar T, Medeiros LJ, Wang SA, Bueso-Ramos CE. MLL gene amplification in acute myeloid leukemia and myelodysplastic syndromes is associated with characteristic clinicopathological findings and TP53 gene mutation. Hum Pathol 46(1):65-73, 2015. e-Pub 2014. PMID: 25387813.
124. Wang W, Tang G, Cortes JE, Liu H, Ai D, Yin CC, Li S, Khoury JD, Bueso-Ramos C, Medeiros LJ, Hu S. Chromosomal rearrangement involving 11q23 locus in chronic myelogenous leukemia: a rare phenomenon frequently associated with disease progression and poor prognosis. J Hematol Oncol 8(32):32, 2015. e-Pub 2015. PMID: 25888368.
125. Loghavi S, Alayed K, Aladily TN, Zuo Z, Ng SB, Tang G, Hu S, Yin CC, Miranda RN, Medeiros LJ, Khoury JD. Stage, age, and EBV status impact outcomes of plasmablastic lymphoma patients: a clinicopathologic analysis of 61 patients. J Hematol Oncol 8(1):65, 2015. e-Pub 2015. PMID: 26055271.
126. Loghavi S, Zuo Z, Ravandi F, Kantarjian HM, Bueso-Ramos C, Zhang L, Singh RR, Patel KP, Medeiros LJ, Stingo F, Routbort M, Cortes J, Luthra R, Khoury JD. Clinical Features of De Novo Acute Myeloid Leukemia with Concurrent DNMT3A FLT3 and NPM1 Mutations. J Hematol Oncol 7(1):74, 2014. e-Pub 2014. PMID: 25281355.
127. Zhang L, Singh RR, Patel KP, Stingo F, Routbort M, You MJ, Miranda RN, Garcia-Manero G, Kantarjian HM, Medeiros LJ, Luthra R, Khoury JD. BRAF Kinase Domain Mutations Are Present in a Subset of Chronic Myelomonocytic Leukemia with Wild-Type RAS. Am J Hematol 89(5):499-504, 2014. e-Pub 2014. PMID: 24446311.
128. Tang G, Zhang L, Fu B, Hu J, Lu X, Hu S, Patel A, Goswami M, Khoury JD, Garcia-Manero G, Medeiros LJ, Wang SA. Cytogenetic Risk Stratification of 417 Patients with Chronic Myelomonocytic Leukemia from a Single Institution. Am J Hematol 89(8):813-8, 2014. e-Pub 2014. PMID: 24782398.
129. Sasaki K, Pemmaraju N, Westin JR, Wang WL, Khoury JD, Podoloff DA, Moon B, Daver N, Borthakur G. A Single Case of Rosai-Dorfman Disease Marked by Pathologic Fractures, Kidney Failure, and Liver Cirrhosis Treated with Single-Agent Cladribine. Front Oncol 4:297, 2014. e-Pub 2014. PMID: 25401088.
130. Shah S, Loghavi S, Garcia-Manero G, Khoury JD. Discovery of imatinib-responsive FIP1L1-PDGFRA mutation during refractory acute myeloid leukemia transformation of chronic myelomonocytic leukemia. J Hematol Oncol 7:26, 2014. e-Pub 2014. PMID: 24669761.
131. Giordano A, Gao H, Cohen EN, Anfossi S, Khoury JD, Hess K, Krishnamurthy S, Tin S, Cristofanilli M, Hortobagyi GN, Woodward WA, Lucci A, Reuben JM. Clinical relevance of cancer stem cells in bone marrow of early breast cancer patients. Ann Oncol 24(10):2515-21, 2013. e-Pub 2013. PMID: 23798614.
132. Rajabi B, Khoury JD, Brewer C, Goodman OB. Urothelial bladder carcinoma with choriocarcinomatous differentiation presenting with a false-positive pregnancy test. Am J Med Sci 346(3):256-8, 2013. PMID: 23147379.
133. Khoury JD, Tannir NM, Williams MD, Chen Y, Yao H, Zhang J, Thompson EJ, TCGA Network, Meric-Bernstam F, Medeiros LJ, Weinstein JN, Su X. The Landscape of DNA Virus Associations Across Human Malignant Cancers Using RNA-Seq: An Analysis of 3775 Cases. J Virol 87(16):8916-26, 2013. e-Pub 2013. PMID: 23740984.
134. Alayed K, Patel KP, Konoplev S, Singh RR, Routbort MJ, Reddy N, Pemmaraju N, Zhang L, Shaikh AA, Aladily TN, Jain N, Luthra R, Medeiros LJ, Khoury JD. TET2 Mutations, Myelodysplastic Features, and a Distinct Immunoprofile Characterize Blastic Plasmacytoid Dendritic Cell Neoplasm in the Bone Marrow. Am J Hematol 88(12):1055-61, 2013. e-Pub 2013. PMID: 23940084.
135. Jain N, Khoury JD, Pemmaraju N, Kollipara P, Kantarjian H, Verstovsek S. Imatinib Therapy in a Patient with Suspected Chronic Neutrophilic Leukemia and FIP1L1-PDGFRA Rearrangement. Blood 122(19):3387-8, 2013. PMID: 24203930.
136. Turner JF, Khoury JD, Ruckdeschel JC. Granulomatous solitary pulmonary nodule. J Bronchol Interv Pulmonol 18(1):111-112, 2011. PMID: 23169031.
137. Deyrup AT, Miettinen M, North PE, Khoury JD, Tighiouart M, Spunt SL, Parham DM, Shehata BM, Weiss SW. Pediatric cutaneous angiosarcomas: a clinicopathologic study of 10 cases. Am J Surg Pathol 35(1):70-5, 2011. PMID: 21164289.
138. Gollard RP, Rosen L, Anson J, Mason J, Khoury JD. Intramedullary PNET of the spine: long-term survival after combined modality therapy and subsequent relapse. J Pediatr Hematol Oncol 33(2):107-12, 2011. PMID: 21228722.
139. McClure R, Khoury JD, Feldman A, Ketterling R. Clonal relationship between precursor B-cell acute lymphoblastic leukemia and histiocytic sarcoma: a case report and discussion in the context of similar cases. Leuk Res 34(2):e71-3, 2010. e-Pub 2009. PMID: 19744706.
140. Chan F, Goodman O, Fink L, Vogelzang NJ, Pomerantz D, Khoury JD. Dramatically elevated circulating tumor cell numbers in a patient with small cell neuroendocrine carcinoma of the prostate. Arch Pathol Lab Med 134(1):120-123, 2010. PMID: 20073615.
141. VanBrocklin MW, Robinson JP, Lastwika KJ, Khoury JD, Holmen SL. Targeted delivery of NRASQ61R and Cre-recombinase to postnatal melanocytes induces melanoma in Ink4a/Arflox/lox mice. Pigment Cell Melanoma Res 23(4):531-541, 2010. e-Pub 2010. PMID: 20444198.
142. Boomer LA, Bellister SA, Stephenson LL, Hillyard SD, Khoury JD, Youson JH, Gosche JR. Cholangiocyte apoptosis is an early event during induced metamorphosis in the sea lamprey, Petromyzon marinus L. J Pediatr Surg 45(1):114-20, 2010. PMID: 20105590.
143. Khoury JD, Coffin CM, Spunt SL, Anderson JR, Meyer WH, Parham DM. Grading of nonrhabdomyosarcoma soft tissue sarcoma in children and adolescents: a comparison of parameters used for the Fédération Nationale des Centers de Lutte Contre le Cancer and Pediatric Oncology Group Systems. Cancer 116(9):2266-74, 2010. PMID: 20166208.
144. Khoury JD, Adcock DM, Chan F, Symanowski JT, Tiefenbacher S, Goodman O, Paz L, Ma Y, Ward DC, Vogelzang NJ, Fink LM. Increases in quantitative D-dimer levels correlate with progressive disease better than circulating tumor cell counts in patients with refractory prostate cancer. Am J Clin Pathol 134(6):964-9, 2010. PMID: 21088161.
145. Gollard R, Khoury J. Images in HIV/AIDS. HIV and myelodysplasia. AIDS Read 19(4):156-157, 2009.
146. Deyrup AT, Miettinen M, North PE, Khoury JD, Tighiouart M, Spunt SL, Parham D, Weiss SW, Shehata BM. Angiosarcomas arising in the viscera and soft tissue of children and young adults: a clinicopathologic study of 15 cases. Am J Surg Pathol 33(2):264-269, 2009. PMID: 18987547.
147. Balaguer J, Wilson MW, Billups CA, Mancini J, Haik BG, Qaddoumi I, Khoury JD, Rodriguez-Galindo C. Predictive factors of invasion in eyes with retinoblastoma enucleated after eye salvage treatments. Pediatr Blood Cancer 52(3):351-356, 2009. PMID: 19021223.
148. Saab R, Rodriguez-Galindo C, Matmati K, Rehg JE, Baumer SH, Khoury JD, Billups C, Neale G, Helton KJ, Skapek SX. p18Ink4c and p53 act as tumor suppressors in cyclin D1-driven primitive neuroectodermal tumor. Cancer Res 69(2):440-448, 2009. PMID: 19147556.
149. Vanbrocklin MW, Robinson JP, Whitwam T, Guilbeault AR, Koeman J, Swiatek PJ, Vande Woude GF, Khoury JD, Holmen SL. Met amplification and tumor progression in Cdkn2a-deficient melanocytes. Pigment Cell Melanoma Res 22(4):454-460, 2009. e-Pub 2009. PMID: 19422607.
150. Ng SB, Khoury JD. Epstein-Barr virus in lymphoproliferative processes: an update for the diagnostic pathologist. Adv Anat Pathol 16(1):40-55, 2009. PMID: 19098466.
151. Neale G, Su X, Morton CL, Phelps D, Gorlick R, Lock RB, Reynolds CP, Maris JM, Friedman HS, Dome J, Khoury JD, Triche TJ, Seeger RC, Gilbertson R, Khan J, Smith MA, Houghton PJ. Molecular characterization of the pediatric preclinical testing panel. Clin Cancer Res 14(14):4572-4583, 2008. PMID: 18628472.
152. Freeman SS, Allen SW, Ganti R, Wu J, Ma J, Su X, Neale G, Dome JS, Daw NC, Khoury JD. Copy number gains in EGFR and copy number losses in PTEN are common events in osteosarcoma tumors. Cancer 113(6):1453-1461, 2008. PMID: 18704985.
153. Yoon KJ, Phelps DA, Bush RA, Remack JS, Billups CA, Khoury JD. ICAM-2 expression mediates a membrane-actin link, confers a nonmetastatic phenotype and reflects favorable tumor stage or histology in neuroblastoma. PLoS One 3(11):e3629, 2008. e-Pub 2008. PMID: 18978946.
154. Goodin GS, McCarville MB, Thibodeau SN, Skapek SX, Khoury JD, Spunt SL. Prolactinoma as the first manifestation of Gardner's syndrome. Pediatr Blood Cancer 50(2):409-12, 2008. PMID: 16862550.
155. Weiss A, Khoury JD, Hoffer FA, Wu J, Billups CA, Heck RK, Quintana J, Poe D, Rao BN, Daw NC. Telangiectatic osteosarcoma: The St. Jude Children's Research Hospital's experience. Cancer 109(8):1627-1637, 2007. PMID: 17351949.
156. Gupta H, Conrad J, Khoury JD, McGregor LM, Krasin MJ, Dome JS, Santana VM, Davidoff AM. Significance of pleural effusion in neuroblastoma. Pediatr Blood Cancer 49(7):906-908, 2007. PMID: 17417797.
157. McCarville MB, Hoffer FA, Adelman CS, Khoury JD, Li C, Skapek SX. MRI and biologic behavior of desmoid tumors in children. AJR Am J Roentgenol 189(3):633-40, 2007. PMID: 17715111.
158. Saab R, Khoury JD, Krasin M, Davidoff AM, Navid F. Desmoplastic small round cell tumor in childhood: the St. Jude Children's Research Hospital experience. Pediatr Blood Cancer 49(3):274-9, 2007. PMID: 16685737.
159. Weiss A, Khoury JD, Kaste SC, Spunt SL. St. Jude Children's Research Hospital, Memphis, Tennessee: gestational choriocarcinoma. Pediatr Blood Cancer 47(5):640-6, 2006. PMID: 16220549.
160. Saab R, Bills JL, Miceli AP, Anderson CM, Khoury JD, Fry DW, Navid F, Houghton PJ, Skapek SX. Pharmacologic inhibition of cyclin-dependent kinase 4/6 activity arrests proliferation in myoblasts and rhabdomyosarcoma-derived cells. Mol Cancer Ther 5(5):1299-308, 2006. PMID: 16731763.
161. Spunt SL, Rodriguez-Galindo C, Fuller CE, Harper J, Krasin MJ, Billups CA, Khoury JD. Ewing sarcoma family tumors that arise after treatment of primary childhood cancer. Cancer 107(1):201-206, 2006. PMID: 16721801.
162. Ganti R, Skapek SX, Zhang J, Fuller CE, Wu J, Billups CA, Breitfeld PP, Dalton JD, Meyer WH, Khoury JD. Expression and genomic status of EGFR and ErbB-2 in alveolar and embryonal rhabdomyosarcoma. Mod Pathol 19(9):1213-1220, 2006. e-Pub 2006. PMID: 16729016.
163. Hartford CM, Wodowski KS, Rao BN, Khoury JD, Neel MD, Daw NC. Osteosarcoma among children aged 5 years or younger: the St. Jude Children's Research Hospital experience. J Pediatr Hematol Oncol 28(1):43-7, 2006. PMID: 16394893.
164. Lai R, Navid F, Rodriguez-Galindo C, Liu T, Fuller CE, Ganti R, Dien J, Dalton J, Billups C, Khoury JD. STAT3 is activated in a subset of the Ewing sarcoma family of tumours. J Pathol 208(5):624-32, 2006. PMID: 16463269.
165. Yared MA, Khoury JD, Medeiros LJ, Rassidakis GZ, Lai R. Activation status of the JAK/STAT3 pathway in mantle cell lymphoma. Arch Pathol Lab Med 129(8):990-996, 2005. PMID: 16048411.
166. Khoury JD, Rassidakis GZ, Medeiros LJ, Amin HM, Lai R. Methylation of SHP1 gene and loss of SHP1 protein expression are frequent in systemic anaplastic large cell lymphoma. Blood 104(5):1580-1, 2004. PMID: 15317731.
167. Herling M, Khoury JD, Washington LT, Duvic M, Keating MJ, Jones D. A systematic approach to diagnosis of mature T-cell leukemias reveals heterogeneity among WHO categories. Blood 104(2):328-335, 2004. e-Pub 2004. PMID: 15044256.
168. Khoury JD, Jones D, Yared MA, Manning JT, Abruzzo LV, Hagemeister FB, Medeiros LJ. Bone marrow involvement in patients with nodular lymphocyte predominant Hodgkin lymphoma. Am J Surg Pathol 28(4):489-495, 2004. PMID: 15087668.
169. Abrahams NA, MacLennan GT, Khoury JD, Ormsby AH, Tamboli P, Doglioni C, Schumacher B, Tickoo SK. Chromophobe renal cell carcinoma: a comparative study of histological, immunohistochemical and ultrastructural features using high throughput tissue microarray. Histopathology 45(6):593-602, 2004. PMID: 15569050.
170. Khoury JD, Shephard MN, Moran CA. Cystic sclerosing haemangioma of the lung. Histopathology 43(3):239-43, 2003. PMID: 12940776.
171. Khoury JD, Amin HM, Jorgensen JL, Ostrowski ML, Bloom MG, Medeiros LJ. Composite thymoma and chronic lymphocytic leukemia/small lymphocytic lymphoma involving the anterior mediastinum. Arch Pathol Lab Med 127(2):e76-79, 2003. PMID: 12562258.
172. Khoury JD, Sen F, Abruzzo LV, Hayes K, Glassman A, Medeiros LJ. Cytogenetic findings in blastoid mantle cell lymphoma. Hum Pathol 34(10):1022-1029, 2003. PMID: 14608536.
173. Khoury JD, Medeiros LJ, Rassidakis GZ, Yared MA, Tsioli P, Leventaki V, Schmitt-Graeff A, Herling M, Amin HM, Lai R. Differential expression and clinical significance of tyrosine phosphorylated STAT3 in ALK+ and ALK- anaplastic large cell lymphoma. Clin Cancer Res 9(10):3692-3699, 2003. PMID: 14506160.
174. Khoury JD, Medeiros LJ, Rassidakis GZ, McDonnell TJ, Abruzzo LV, Lai R. Expression of Mcl-1 in mantle cell lymphoma is associated with high-grade morphology, a high proliferative state, and p53 overexpression. J Pathol 199(1):90-7, 2003. PMID: 12474231.
175. Khoury JD, Abrahams NA, Levin HS, MacLennan GT. The utility of epithelial membrane antigen and vimentin in the diagnosis of chromophobe renal cell carcinoma. Ann Diagn Pathol 6(3):154-158, 2002. PMID: 12089725.
176. Khoury JD, Medeiros LJ, Manning JT, Sulak LE, Bueso-Ramos C, Jones D. CD56(+) TdT(+) blastic natural killer-cell tumor of the skin: a primitive systemic malignancy related to myelomonocytic leukemia. Cancer 94(9):2401-2408, 2002.
177. Gilmore A, Khoury JD, Karim FW, Ballock RT. Bizarre parosteal osteochondromatous proliferation of bone (BPOP): an unusual foot mass in a child. Foot Ankle Int 21(5):404-407, 2000. PMID: 10830659.
178. Khoury JD, Dawson DM, Connell CF, Bostwick DG, MacLennan GT. Expression of the macrophage associated antigen CD68/KP1 by tumor cells of sarcomatoid renal cell carcinoma. J Urol Pathol 11:81-88, 1999.
179. Duncavage E, Advani RH, Agosti S, Foulis P, Gibson C, Kang L, Khoury JD, Medeiros LJ, Ohgami RS, O'Malley DP, Patel KP, Rosenbaum JN, Wilson C, Members of the Cancer Biomarker Reporting Committee, College of American Pathologists. Template for Reporting Results of Biomarker Testing of Specimens From Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma. Arch Pathol Lab Med. e-Pub 2016. PMID: 27081879.
180. Duncavage E, Advani RH, Agosti S, Foulis P, Gibson C, Kang L, Khoury JD, Medeiros LJ, Ohgami RS, O'Malley DP, Patel KP, Rosenbaum JN, Wilson C, Members of the Cancer Biomarker Reporting Committee, College of American Pathologists. Template for Reporting Results of Biomarker Testing of Specimens From Patients With Diffuse Large B-Cell Lymphoma, Not Otherwise Specified. Arch Pathol Lab Med. e-Pub 2016. PMID: 27081876.
181. Liu W, Hu S, Konopleva M, Khoury JD, Kalhor N, Tang G, Bueso-Ramos CE, Jorgensen JL, Lin P, Medeiros LJ, Lu X. De Novo MYC and BCL2 Double-hit B-Cell Precursor Acute Lymphoblastic Leukemia (BCP-ALL) in Pediatric and Young Adult Patients Associated With Poor Prognosis. Pediatr Hematol Oncol 11:1-13. e-Pub 2015. PMID: 26558423.
182. Short NJ, Kantarjian HM, Sasaki K, Cortes JE, Ravandi F, Thomas DA, Garcia-Manero G, Khouri I, Kebriaei P, Champlin RE, Pierce S, Issa GC, Konopleva M, Kadia TM, Bueso-Ramos C, Khoury JD, Jain N, O'Brien SM, Jabbour E. Prognostic significance of day 14 bone marrow evaluation in adults with Philadelphia chromosome-negative acute lymphoblastic leukemia. Cancer. e-Pub 2016. PMID: 27508525.
183. Xu J, Liu JL, Medeiros LJ, Huang W, Khoury JD, McDonnell TJ, Tang G, Schlette E, Yin CC, Bueso-Ramos CE, Lin P, Li S. MYC Rearrangement and MYC/BCL2 Double Expression but not Cell-of-Origin Predict Prognosis in R-CHOP-Treated Diffuse Large B Cell Lymphoma. Eur J Haematol. e-Pub 2020. PMID: 31944390.
184. Garces S, Yin CC, Miranda RN, Patel KP, Li S, Xu J, Thakral B, Poppiti RJ, Medina AM, Sriganeshan V, Castellano-Sánchez A, Khoury JD, Garces JC, Medeiros LJ. Clinical, histopathologic, and immunoarchitectural features of dermatopathic lymphadenopathy: an update. Mod Pathol. e-Pub 2020. PMID: 31896812.
185. Sukswai N, Jung HR, Amr SS, Ng SB, Sheikh SS, Lyapichev K, El Hussein S, Loghavi S, Agbay RLMC, Miranda RN, Medeiros LJ, Khoury JD. Immunopathology of Kikuchi-Fujimoto Disease: A reappraisal using novel immunohistochemistry combinations. Histopathology. e-Pub 2019. PMID: 31854007.
186. Lyapichev KA, Sukswai N, Wang XI, Khoury JD, Medeiros LJ. Hydroa Vacciniforme-Like Lymphoproliferative Disorder With Progression to EBV+ Cytotoxic Peripheral T-Cell Lymphoma. Am J Dermatopathol. e-Pub 2019. PMID: 31313696.
187. Lyapichev KA, Piña-Oviedo S, Medeiros LJ, Evans MG, Liu H, Miranda AR, Hunt KK, Clemens MW, Stewart JM, Amin MB, Quesada AE, Chai SM, Di Napoli A, Yoga A, Dave SK, Wistuba II, Wu Y, Bueso-Ramos CE, Schlette EJ, Ferrufino-Schmidt MC, Loghavi S, Khoury JD, Young KH, Miranda RN. A proposal for pathologic processing of breast implant capsules in patients with suspected breast implant anaplastic large cell lymphoma. Mod Pathol. e-Pub 2019. PMID: 31383966.
188. Shen J, Li S, Medeiros LJ, Lin P, Wang SA, Tang G, Yin CC, You MJ, Khoury JD, Iyer SP, Miranda RN, Xu J. PD-L1 expression is associated with ALK positivity and STAT3 activation, but not outcome in patients with systemic anaplastic large cell lymphoma. Mod Pathol. e-Pub 2019. PMID: 31383967.

Invited Articles

1. Ng SB, Khoury JD. Epstein-Barr Virus in Lymphoproliferative Disorders: An update for the diagnostic pathologist. Adv Anat Pathol 16(1):97-105, 2009.
2. Khoury JD. Ewing sarcoma family of tumors: a model for the new era of integrated laboratory diagnostics. Expert Rev Mol Diagn 8(1):97-105, 2008.
3. Khoury JD. Ewing sarcoma family of tumors. Adv Anat Pathol 12(4):212-220, 2005.

Other Articles

1. Khoury JD, Dogan A, Foucar K, Hsi ED, Hussong JW, Liang M, Lim M, Lin P, McKenna RW, Perkins SL, Reichard KK, Yared M, Zangari M Protocol for the Examination of Specimens From Patients With Plasma Cell Neoplasms. College of American Pathologists Cancer Protocols, 2015.
2. Duncavage E, Advani HR, Alsbeh R, Foulis P, Gibson C, Kang L, Khoury JD, Medeiros LJ, Ohgami RS, O'Malley DP, Patel KP, Wilson C Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Biomarker Template. College of American Pathologists Cancer Protocols, 2014.
3. Duncavage E, Advani RH, Agosti S, Alsabeh R, Foulis P, Gibson C, Kang L, Khoury JD, Medeiros LJ, Ohgami RS, O'Malley DP, Patel KP, Wilson C Template for Reporting Results of Biomarker Testing of Specimens From Patients With Diffuse Large B-Cell Lymphoma, Not Otherwise Specified (NOS). College of American Pathologists Cancer Protocols, 2014.
4. Kelley TW, Alsabeh R, Arber DA, Gibson C, Jones D, Khoury JD, Medeiros BC, O'Malley DP, Patel KP, Pilichowska M, Vasef MA, Wallentine J, Zehnder JL Template for Reporting Results of Biomarker Testing for Myeloproliferative Neoplasms. College of American Pathologists Cancer Protocols, 2014.
5. Hussong JW, Arber DA, Bradley KT, Brown MS, Chang CC, De Baca ME, Ellis DW, Foucar K, Hsi ED, Jaffe ES, Khoury JD, Lill M, McClure SP, Medeiros LJ, Perkins SL Protocol for the Examination of Specimens From Patients With Hodgkin Lymphoma. College of American Pathologists Cancer Protocols, 2013.
6. Hussong JW, Arber DA, Bradley KT, Brown MS, Chang CC, De Baca ME, Ellis DW, Foucar K, Hsi ED, Jaffe ES, Khoury JD, Lill M, McClure SP, Medeiros LJ, Perkins SL Protocol for the Examination of Specimens From Patients With Non-Hodgkin Lymphoma/Lymphoid Neoplasms. College of American Pathologists Cancer Protocols, 2013.
7. Finegold MJ, Bowen J, Lopez-Terrada D, Washington MK, Hill DA, Khoury JD Protocol for the Examination of Specimens From Pediatric Patients With Hepatoblastoma. College of American Pathologists Cancer Protocols, 2013.

Editorials

1. Khoury JD, Catenacci DVT. Next-Generation Companion Diagnostics: Promises, Challenges, and Solutions. Arch Pathol Lab Med 139(1):11-3, 2015.

Abstracts

1. Hong Fang, Hannah Beird, Shimin Hu, Carlos Bueso-Ramos, Guilin Tang, Zhenya Tang, M. James You, Joseph Khoury, L. Jeffrey Medeiros, Wei Wang. T(6;14)(q25;q32) Involves BCL11B and is Highly Associated with Mixed Phenotype Acute Leukemia, T/Myeloid. Modern Pathology 33(2):1280, 2020.
2. Julia Garcia-Reyero, Nerea Martinez, Irene Hernandez-Alconchel, Sonia Gonzalez de Villambrosia, Angela Gomez Mediavilla, Sanam Loghavi, Ainara Gonzalez, Emanuele d'Amore, Carlo Visco, Joseph Khoury, Santiago Montes-Moreno. Plasmablastic Lymphoma Mutational Profile is Characterized by MYC, STAT3. Modern Pathology 33(2):1300, 2020.
3. Mehrnoosh Tashakori, Sanam Loghavi, Jie Xu, Sherry Pierce, Jeff Jorgensen, Marina Konopleva, Naveen Pemmaraju, Naval Daver, Joseph Khoury, L. Jeffrey Medeiros, Sa Wang, Sergej Konoplev. CD123 Overexpression Significantly Varies in Different Subtypes of Adult Acute Myeloid Leukemia. Modern Pathology 33(2):1396, 2020.
4. Garces S, Medeiros LJ,Khoury JD, Li S, Xu J, Saluja K, Bhattacharjee MB, Yin CC. Cyclin D1 Protein is Overexpressed in Rosai-Dorfman Disease. Modern Pathology, 2019.
5. Mustafa Abdulrazzaq, Valentina Fabiola Sangiogio, Roberto Miranda, Tariq Muzzafar, Joseph Khoury, L. Jeffrey Medeiros, Ali Sakhdari. Pressence of t(14:18)(q32;q21)/IGH-BCL2 Imparts Worse Prognosis in Grade 3B Follicular Lymphoma. Modern Pathology, 2019.
6. Sofia Garces Narvaez, Mario Marques Piubelli, Sheila Siquiera, Vathany Sriganeshan, Ana Medina Castellano-Sanchez, Robert Poppiti, Joseph Khoury, Shaoying Li, Jie Xu, Beenu Thakral, Karan Saluja, Meenakshi Bhattacharjee, Juan Carlos Garces, L. Jeffrey Medeiros, C. Cameron Yin. Cyclin D1 Protein is Overexpressed in Rosai-Dorfman Disease. Modern Pathology, 2019.
7. Garces S, Medeiros LJ, Patel KP, Khoury JD, Manning JT, Li S, Xu J, Gonzalez S, Molgo M, Yin CC. Focal Rosai-Dorfman Disease coexisting with Lymphoma in the same Anatomic site: A Localized Histiocytic Proliferation associated with MAPK/ERK Pathway Activation, 2018.
8. Pradhan D,Khoury JD, Aung P, Tetzlaff M, Torres-Cabala C, Curry J, Ivan D, Prieto V, Nagarajan P. Coincident Merkel Cell Carcinoma and Mantle Cell Lymphoma, 2018.
9. Khouri IF, Wang X, Turturro F, Jabbour E, Carballo-Zarate A, Korbling M, Alousi AA, Oran B, Anderlini P, Ciurea SO, Patel KK, Marin D, Nastoupil LJ, Fanale MA, Samuels BI, Bulbis AM, Medeiros LJ, Khoury JD. Long-term outcomes of non-myeloablative allogeneic stem cell transplantation (alloSCT) in patients with relapsed mantle cell lymphoma (MCL). J Clin Oncol 34:A7551, 2016.
10. McCroskey Z, Khoury JD, Stewart JM, Caraway N. Follicular Lymphoma Diagnosis by Fine Needle Aspiration Biopsies in a Cancer Center. Modern Pathology 29(S2):109A, 2016.
11. Quesada A, Luthra R, Patel KP, Singh R, Routbort M, Loghavi S, Khoury JD, Medeiros LJ, Bueso-Ramos CE, Kanagal-Shamanna R. De Novo Acute Myeloid Leukemia (AML) with RUNX1 Mutations Shows Characteristic Clinicopathologic Features. Modern Pathology 29(S2):371A, 2016.
12. Thakral B, Desai P, Lin P, Yin CC, Tang G, Hu S, Khoury JD, Medeiros LJ, Li S. Prognostic Significance of CD5 Expression in Diffuse Large B-cell Lymphoma in Patients Treated with Rituximab-EPOCH. Modern Pathology 29(S2):378A, 2016.
13. Wang W, Cortes J, Tang G, Khoury JD, Wang S, Bueso-Ramos CE, DiGuiseppe JA, Chen Z, Kantarjian HM, Medeiros LJ, Hu S. Risk Stratification of Additional Chromosomal Changes in Chronic Myelogenous Leukemia in Era of Tyrosine Kinase Inhibitor Therapy. Modern Pathology 29(S2):382A, 2016.
14. Pina-Oviedo S, Medeiros LJ, Clemens MW, Hunt KK, Liu H, Staerkel G, Amin M, Quesada A, Carballo-Zarante A, Miranda A, Wistuba II, Chai M, Di Napoli A, Young KH, Khoury JD, Miranda RN. A Proposal for Pathologic Processing of Breast Capsule Specimens of Patients with Breast Implant-Associated Anaplastic Large Cell Lymphoma without a Grossly Identifiable Mass. Modern Pathology 29(S2):369A, 2016.
15. Li Y, Hu S, Zuo Z, Hong M, Lin P, Li S, Konoplev S, Wang Z, Khoury JD, Young KH, Medeiros LJ, Yin CC. CD5-Positive Follicular Lymphoma: Clinicopathologic Correlation and Outcome in 88 Patients. Modern Pathology 28(S2):359A, 2015.
16. Liu H, Medeiros LJ, Weisenberger DD, Clemens MW, Hunt KK, Chai SM, Amin M, Vdlamani IU, Sohani AR, Ferry JA, Morgan EA, Parkash V, Bhagat G, Yang L, Thomazy V, Kanagal-Shamanna R, Vasef M, Herman CM, Oyarzo M, Narbaitz M, Piccolini J, Lamar W, Porter WR, Hughes C, Baptista M, Tritz D, Zhang D, Khoury JD, Young KH, Miranda RN. Breast Implant-Associated Anaplastic Large Cell Lymphoma (BI-ALCL): A Comprehensive Histopathological Evaluation of 40 Cases With a Proposal for a Pathologic Staging System. Modern Pathology 28(S2):360A, 2015.
17. Loghavi S, Al-Ibraheemi A, Zuo Z, Wang S, Garcia-Manero G, Kantarjian H, Yin CC, Miranda R, Medeiros LJ, Bueso-Ramos CE, Khoury JD. De Novo Myelodysplastic Syndromes With Fibrosis Exhibit an Increased Frequency of TP53 Mutations and p53 Overexpression. Modern Pathology 28(S2):361A, 2015.
18. Shen Q, Tang G, Fu B, Patel KP, Khoury JD, Medeiros LJ, Wang SA. Myeloproliferative-Type Chronic Myelomonocytic Leukemia Exhibits a High Frequency of RAS Mutations and Adverse Clinical Outcomes. Modern Pathology 27(S2):378A, 2014.
19. Zhang L, Wang SA, Khoury JD, Medeiros LJ, Tang G. Cytogenetic Risk in 417 Patients with Chronic Myelomonocytic Leukemia from a Single Institute. Modern Pathology 27(S2):388A, 2014.
20. Loghavi S, Zuo Z, Zhang L, Stingo F, Patel KP, Singh R, Luthra R, Routbort MJ, Medeiros LJ, Cortes J, Ravandi-Kashani F, Kantarjian HM, Khoury JD. De Novo Acute Myeloid Leukemia with DNMT3A, FLT3, and NPM1 Mutations. Modern Pathology 27(S2):359A, 2014.
21. Yabe M, Tang G, Lu X, Kantarjian HM, Garcia-Manero G, Medeiros LJ, Bueso-Ramos C, Khoury JD. Acute myeloid leukemia cases with t(v;5q33-34) do not always have myelodysplastic features but are associated with poor outcome. Clinical Lymphoma, Myeloma & Leukemia, 2014.
22. Loghavi S, Zuo Z, Patel KP, Singh RR, Zhang L, Medeiros LJ, Stingo F, Routbort M, Cortes J, Ravandi F, Kantarjian HM, Bueso-Ramos C, Luthra R, Khoury JD. DNMT3A mutations exert a dominant adverse effect in De Novo acute myeloid leukemia with concurrent FLT3 and NPM1 mutations. Clinical Lymphoma, Myeloma & Leukemia, 2014.
23. Sevcikova K, Zhuang Z, Garcia-Manero G, Alvarez RH, Kantarjian HM, Mego M, Albarracin C, Tang G, Strom SS, Reuben JM, Khoury JD. Characteristics of therapy-related myeloid neoplasms in breast cancer patients. Clinical Lymphoma, Myeloma & Leukemia, 2014.
24. Sevcikova K, Zhuang Z, Garcia-Manero G, Alvarez RH, Kantarjian HM, Mego M, Albarracin C, Tang G, Strom SS, Medeiros LJ, Hortobagyi GN, Reuben JM, Khoury JD. Therapy-Related Myeloid Neoplasms in Breast Cancer Patients: A Single-Institution Report of 150 Cases. Blood 124(21):962, 2014.
25. Alayed KM,Khoury JD, Alshaikh AF, Aladily TN, Konoplev K, Medeiros LJ.. Blastic Plasmacytoid Dendritic Cell Neoplasm in Bone Marrow, a Clinicopathological Description of 14 Cases. Modern Pathology 26(S2):317A, 2013.
26. Zhang L, Aladily TN, Chakhachiro Z, Yao H, Su X, Routbort M, Wang SA, Luthra R, Miranda R, Medeiros LJ, Bueso-Ramos C, Khoury JD. RAS Mutation Is a Poor Prognostic Factor in Patients with Chronic Myelomonocytic Leukemia. Modern Pathology 26(S2):369A, 2013.
27. Su X, Khoury JD, Weinstein JN.. AccuFusion: A highly scalable software tool for detecting gene fusions in TCGA transcriptome sequencing data, 2011.
28. Khoury JD, Adcock DM, Tiefenbacher S,...Fink LM. Changes in circulating tumor cells over time correlates with D-dimer and serum prostate-specific antigen levels in patients with refractory prostate cancer, 2009.
29. Freeman SS, Allen SW, Ganti R, Wu J, Ma J, Su X, Neale GA, Dalton JD, Billups CA, Dome JS, Daw NC, Khoury JD. EGFR Expression and Copy Number Gain Are Common in Pediatric Osteosarcoma Tumors, 2007.
30. Smith RJ, Laningham FH, Laughton S, Onar A, Sanford RA, Khoury JD, Fuller C, Shulkin BL.. Metabolic/histologic characterization of pediatric CNS neoplasms, 2007.
31. Khoury JD, Coffin CM, Anderson JR, Spunt SL, Jenkins JJ, Meyer WH, Parham DM.. Grading of Soft Tissue Sarcoma in Children and Adolescents: Comparative Analysis of the POG and FNCLCC Grading Systems, 2007.
32. Handa S, Tabrizi R, Hurmiz C, Shurtleff S, Downing JR, Khoury JD. A novel scalable and rapidly adaptive informatics system for tissue banks/Platform presentation, 2006.
33. Zhang J, Skapek SX, Fuller CE, Wu J, Billups C, Ganti R, Breitfeld PP, Dalton J, Meyer WH, Khoury JD. Differential expression and copy number status of EGFR and ErbB-2 in alveolar and embryonal rhabdomyosarcoma, 2006.
34. Khoury JD, Navid F, Rodriguez-Galindo C, Dalton J, Jenkins JJ, Fuller CE.. EGFR and ERBB2 protein expression and gene amplification status in Ewing sarcoma family of tumors, 2005.
35. Lai R, Rodriguez-Galindo C, Navid F, Fuller CE, Amin HM, Dalton J, Jenkins JJ, Khoury JD. STAT3 activation in Ewing sarcoma family of tumors, 2005.
36. Khoury JD, Jones D, Yard MA, Manning JT, Abruzzo LV, Medeiros LJ.. Bone marrow disease in nodular lymphocyte predominant Hodgkin disease, 2003.
37. Yared MA, Medeiros LJ, Khoury JD, Rassidakis GZ, Leventaki V, Lai R.. JAK/STAT3 signaling pathway in mantle cell lymphoma, 2003.
38. Khoury JD, Medeiros LJ, Rassidakis GZ, Tsioli P, Leventaki V, Schmitt-Graeff A, herling M, Sarris AH, Lai R.. Prognostic significance of STAT3 activation in systemic anaplastic large cell lymphoma, 2003.
39. Khoury JD, Huaringa AJ, Tamboli P, Ayala AG, Ro JY.. Gallium-67 scintigraphy scan in the assessment of diffuse interstitial lung diseases: a pathologic correlation, 2003.
40. Yared MA, Medeiros LJ, Khoury JD, Rassidakis GZ, Leventaki V, Lai R.. Correlation of SOCS3 expression with STAT3 activation in mantle cell lymphoma, 2003.
41. Khoury JD, Medeiros LJ, Rassidakis GZ, McDonnell TJ, Abruzzo LV, Lai R.. Apoptosis and proliferation in mantle cell lymphoma: correlation with expression of the antiapoptotic protein, MCL-1, 2002.
42. Khoury JD, Abrahams NA, Levin HJ, MacLennan GT.. Chromophobe renal cell carcinoma expresses epithelial membrane antigen and not vimentin, 2001.
43. Abrahams NA, Ormsby AO, Maclennan GT, Khoury JD , Tickoo SK.. Chromophobe renal cell carcinoma and its mimickers: a reappraisal of the morphologic characteristics used in the differential diagnosis by genitourinary pathologists, 2001.
44. Khoury JD, Compitello N, Koç O, Fujioka H, Emancipator S, Renne R.. Mesenchymal stem cells and CD34+ hematopoietic stem cells are susceptible to KSHV infection in vitro, 2001.
45. Khoury JD, Lee T, Willis J, Chak A.. Clinical significance of non-neoplastic lesions of the ampulla of Vater, 2000.

Book Chapters

1. Randhawa JK, Khoury JD, Ravandi-Kashani F. Adult Acute Myeloid Leukemia. In: MD Anderson Manual of Medical Oncology. Third. McGraw-Hill, 2016.
2. Khoury JD. Pediatric Renal Neoplasms. In: Practical Renal Pathology. Elsevier, 2009.
3. Khoury JD. Ewing Sarcoma Family of Tumors. In: Bone Tumors. Elsevier, 2009.
4. Rodriguez-Galindo C, Navid F,Khoury JD, Krasin M.. Ewing sarcoma family of tumors. In: Pediatric Sarcomas. Springer-Verlag, 2006.
5. Khoury JD. Nephroblastic Neoplasms. In: Clinics in Laboratory Medicine: Renal Tumors. Elsevier, 341-361, 2005.

Books (edited and written)

1. Parham DM, Khoury JD, McCarville B. Pediatric Malignancies: Pathology and Imaging. Springer, 2014.
2. Miranda RN, Khoury JD, Medeiros LJ. Atlas of Lymph Node Pathology. Springer, 2013.

Letters to the Editor

1. Wang W, Wang SA, Medeiros LJ, Khoury JD. Response to Dr. Bain's comment on our review article: Pure Erythroid Leukemia. Am J Hematol 92: E622, 2017.
2. Baker TP, Khoury JD. In Reply. Arch Pathol Lab Med 141: 16-17, 2017.
3. Khoury JD, Vogelzang NJ, Fink LM. Call for revision of CAP-mandated requirements for retention of Laboratory records and materials. Archive Pathology Lab Medicine 132: 1712-1713, 2008.
4. Geller JI, Khoury JD, Dome JS. Local lymph node involvement does not predict poor outcome in pediatric renal cell carcinoma. Cancer 103: 1318, 2005.